SANDUR MANGANESE & IRON ORES
|
|
BOM : 504918     NSE : SANDUMA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Apr 18,2024 |
Price(EOD): ₹ 465.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Mining & Minerals |
MCap: ₹ 7,533.81 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SANDUR MANGANESE & IRON ORES | 1.2% | -14.8% | 141.3% |
COAL INDIA | 4.1% | -1.8% | 98.8% |
NMDC | 1.5% | -14.8% | 83% |
KIOCL | 1.5% | -22.2% | 131.4% |
GUJARAT MINERAL DEVELOPMENT CORPORATION | 2.9% | -15% | 163.3% |
MOIL | 3% | -0.4% | 90.6% |
ASHAPURA MINECHEM | 14.8% | -11.8% | 217.4% |
RAGHAV PRODUCTIVITY ENHANCERS | 4% | -4.2% | 49.9% |
20 MICRONS | -1.7% | -7.7% | 119.5% |
FUNDAMENTAL ANALYSIS OF SANDUR MANGANESE & IRON ORES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SANDUR MANGANESE & IRON ORES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
30.09
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 250.45 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] 3.9
P/B Calculated based on Book Value of Rs 1,933.70 Cr
[Latest Year - Mar2023 - Consolidated Results ] 5.76
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,308.07 Cr
[Latest Qtr - Dec2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
337% 443% 509% |
SHARE PRICE MOMENTUM OF SANDUR MANGANESE & IRON ORES
SANDUR MANGANESE & IRON ORES vs SENSEX
DEBT OF SANDUR MANGANESE & IRON ORES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.11 0.19 0.37 0.22 |
0.11 0.61 0.27 0.33 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SANDUR MANGANESE & IRON ORES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SANDUR MANGANESE & IRON ORES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-17.2% -54.43% -63.23% -63.02% |
-60.55% -74.34% -76.48% -76.31% |
QtrlyTrend |
-8 | |
Latest Qtr: Dec2023 | ||
Quarterly Result Analysis → |
SANDUR MANGANESE & IRON ORES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ENERGY | 0.1% | 5.6% | 59.1% |
S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
You may also like the below Video Courses
FAQ about SANDUR MANGANESE & IRON ORES
Is SANDUR MANGANESE & IRON ORES good for long term investment?
As on Apr 18,2024, the Fundamentals of SANDUR MANGANESE & IRON ORES look Strong and hence it may be good for long term investment! See Financial Performance of SANDUR MANGANESE & IRON ORES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SANDUR MANGANESE & IRON ORES UnderValued or OverValued?
As on Apr 18,2024, SANDUR MANGANESE & IRON ORES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SANDUR MANGANESE & IRON ORES ?
As on Apr 18,2024, the Intrinsic Value of SANDUR MANGANESE & IRON ORES is Rs. 85.68 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 106.35
Fair Value [Median EV / Sales Model] : Rs. 85.68
Fair Value [Median Price / Sales Model] : Rs. 76.31
Estimated Median Fair Value of SANDUR MANGANESE & IRON ORES : Rs. 85.68
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.